<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-21T02:44:11Z</responseDate><request verb="GetRecord" identifier="oai:macsphere.mcmaster.ca:11375/16562" metadataPrefix="dim">https://prod-ms-be.lib.mcmaster.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:macsphere.mcmaster.ca:11375/16562</identifier><datestamp>2026-09-24T00:42:10Z</datestamp><setSpec>com_11375_271</setSpec><setSpec>col_11375_272</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor">Selvaganapathy, P. Ravi</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author">Yang, Jun</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department" lang="en_US">Biomedical Engineering</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2014-12-16T15:41:30Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2014-12-16T15:41:30Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2015-06</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/11375/16562</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://doi.org/10.71548/13970</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">Sepsis is an uncontrolled response to infection. Severe sepsis is associated with &#xd;
organ dysfunction, and has mortality rate of 30-50%. Identification of severity of sepsis &#xd;
and  prediction  on  mortality  is  crucial  in  making  clinical  decisions.  Recently,  cell-free &#xd;
DNA (cfDNA) in blood was found to have high discriminative power in predicting ICU &#xd;
mortality in patients with severe sepsis. In an analysis of 80 severely septic patients, the &#xd;
mean  cfDNA  level  in  survivors  (1.16±0.13μg/ml)  was  similar  to  that  of  healthy &#xd;
volunteers (0.93±0.76μg/ml), while that of non-survivors (4.65±0.48μg/ml) was notably &#xd;
higher.  Therefore,  rapid  quantification  of  cfDNA  concentration  in  blood  will  enable &#xd;
physicians to quickly predict mortality of sepsis and decide on treatment.  &#xd;
Current  methods  for  quantification  of  cfDNA  involve  multiple  steps  including &#xd;
centrifugation,  DNA-extraction  from  plasma,  and  its  quantification  either  through &#xd;
spectroscopic methods or quantitative PCR. The whole process is time consuming, thus is &#xd;
not  suitable  for  immediate  bedside  assessment.  To  solve  the  problems,  a  microfluidic &#xd;
device  is  designed  and  fabricated  in  this  thesis,  which  is  potential  for  cfDNA &#xd;
quantification  directly  using  blood  in  5  minutes.  The  goal  is  to  use  this  device  for &#xd;
distinguishing  survivors  or  healthy  donors  from  non-survivors  in  patients  with  severe &#xd;
sepsis.   The  two-layer  device  consists  of  a  sample  channel  (top)  and  an  accumulation &#xd;
channel (bottom) that intersect each other. The accumulation channel is preloaded with &#xd;
1%  agarose  gel,  and  the  blood  containing  cfDNA  and  intercalating  fluorescent  dye  is &#xd;
loaded  in  the  sample  channel.  Fluorescently  labeled  DNA  is  able  to  be  trapped  and &#xd;
concentrated at the intersection using a DC electric field, and fluorescent intensity of the &#xd;
accumulated  DNA  is  representative  of  its  concentration  in  the  blood.  The  simulated &#xd;
electric field in the sample channel reveals that both the magnitude and the gradient of &#xd;
electric field reach their maximum values at the intersection. Force analysis shows that &#xd;
DNA was driven into the gel by the dominate electrophoretic force, while red blood cells &#xd;
moved away from the gel due to a strong dielectrophoretic force. &#xd;
In this thesis, 4 types of samples have been used to characterize the performance &#xd;
of the device. It showed that DNA was efficiently accumulated at the intersection, and the &#xd;
fluorescent  intensity  could  be  measured  using  a  fluorescent  microscope.  Samples  from &#xd;
healthy donors  were  able to  be distinguished from  that of severely  septic  patients  in  5 &#xd;
minutes.  However,  better  resolution  was  needed  for  differentiating  various  cfDNA &#xd;
concentrations in patient samples. The discussion on the effect of applied voltage showed &#xd;
that  9V  is  an  optimized  setting  compared  with  3V  and  15V.  In  addition,  it  has  been &#xd;
proved that the fluorescent reagent could be immobilized in the device and the sample &#xd;
preparation could be absolutely eliminated. In  summary,  the  device  proposed  in  this  thesis  is  capable  of  distinguishing &#xd;
severely septic patients  from healthy donors using  clinical plasma in 5  minutes, and is &#xd;
potential  to  be  applied  in  clinical  blood  samples.  It  has  low  cost,  and  is  ready  to  be &#xd;
developed into a fully functioned system. This tool can be a valuable addition to the ICU &#xd;
to rapidly assess the severity of sepsis for informed decision making.</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degreetype" lang="en_US">Thesis</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree" lang="en_US">Master of Applied Science (MASc)</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso" lang="en_US">en</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Microfluidic device</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">cell-free DNA</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Severe sepsis</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">Design &amp; Fabrication of a Microfluidic Device for Clinical Outcome Prediction of Severe Sepsis</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">Thesis</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>